Published in

Taylor and Francis Group, Cancer Investigation, 5(26), p. 491-498

DOI: 10.1080/07357900701829785

Links

Tools

Export citation

Search in Google Scholar

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

Journal article published in 2008 by Christos A. Papadimitriou, Pavlos Papakostas, Eleni Timotheadou, Gerasimos Aravantinos ORCID, Aristotelis Bamias, George Fountzilas
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO